PROSTATE SCREENING
Prostate Cancer is the most common male tumor.
Multiparametric MRI has become a pivotal non-invasive tool for initial screening and diagnosis. Large multicentric studies have shown a highly superior sensitivity compared to conventional invasive transrectal biopsy.
Multiparametric MRI leads to a higher number of detected clinically significant cancer improving clinical outcome and socio-economic benefit. We have vast clinical experience in this field and are involved in large prospective trials. Our experience helps you to tailor efficient MR-protocols, to improve your diagnostic accuracy and optimize your impact on clinical management.
The following images demonstrate how the combination of different MRI-techniques can increase the diagnostic accuracy when imaging prostate cancer.
The data of the MRI-Images can then be fused with computer systems and precise biopsy samples can be taken out of the suspicious area.
In normal MRI-Images a suspicious area can be seen in the prostate (white arrow).
In additional sequences, called diffusion-weighted sequences, the area shows a highly suspicious finding
In dynamic sequences after administration of contrast media a higher perfusion can be seen. The combination of all three findings makes the finding suspicious for prostate cancer.